Insights into the Relative DNA Binding Affinity and Preferred Binding Mode of Homologous Compounds Using Isothermal Titration Calorimetry (ITC) by McKnight, Ruel E.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 6 
 
 
 
 
© 2013 McKnight, licensee InTech. This is an open access chapter distributed under the terms of the 
Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits 
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 
Insights into the Relative DNA Binding  
Affinity and Preferred Binding Mode  
of Homologous Compounds Using  
Isothermal Titration Calorimetry (ITC) 
Ruel E. McKnight 
Additional information is available at the end of the chapter 
http://dx.doi.org/10.5772/54061 
1. Introduction 
1.1. Drug-DNA interactions 
Many biologically significant compounds have been known, for several decades now, to 
bind non-covalently to nucleic acids.[1-7] Ever since the discovery of the structure of DNA 
in the 1950s, DNA has been a target for many therapeutic compounds. Several of these 
compounds have been found to bind to DNA while interfering with the activity of many 
vital enzymes and protein factors involved in DNA metabolism. Others cleave DNA or 
cause DNA cross-linking (for example, cisplatin) interfering with cell division and leading 
to apoptosis. As a result, several DNA-binding compounds have been identified as 
therapeutic agents in especially the anti-cancer and anti-pathogenic classes. Some of the 
most notable members of these classes include the Streptomyces derived anthracyclins e.g., 
daunomycin (daunorubicin) and doxorubicin, have been used for decades, initially as  
antibiotics, then mainly as antitumor agents.[8] Other known DNA binding agent include 
mitoxantrone, which has been particularly useful in the treatment of breast cancers, the 
glycopeptide antibiotic bleomycin which has been used in the treatment of Hodgkin’s 
lymphoma and testicular cancer, amsacrine, bisantrene and various porphyrin derivatives. 
Even though many of these compounds have exhibited therapeutic potency, there still exist 
the accompanying unwanted side-effects, due mainly to the lack of selectivity and DNA 
targeting. Now, even after decades of studies of drug-DNA interactions, the existence of 
deleterious side-effects remains a huge area of concern and presents the main barrier for 
progress within the field. So, the question of whether a certain molecule will bind to a 
specific DNA sequence is currently being probed by several research groups. If we are to 
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approach the problem from a fundamental level, such efforts must rely heavily on a 
fundamental understanding of the predominant contributions to drug-DNA interactions. 
Although ligand-DNA interactions have been studied, so far there have only been a handful 
of studies that have probed the factors that govern DNA-binding using homologous series 
of compounds. This information is especially relevant to the rationale design of novel 
therapeutics with improved efficacy and specificity. The proposed chapter is designed to 
yield an understanding of how various features of small molecules govern their binding to 
DNA and will provide insights into ligand-DNA interactions by studying binding trends 
within homologous series of compounds. Several studies have suggested that some DNA 
binding molecules exhibit more than one binding mode while binding in a sequence specific 
manner. In fact, some researchers have proposed that the therapeutic efficiency of these 
drugs may be linked to their ability to exhibit mixed binding modes.[9,10] These modes 
primarily involve intercalation, where planar aromatic molecules slide between adjacent 
DNA base pairs resulting in significant perturbation of the DNA, and/or minor-groove 
binding, where molecules with the requisite flexibility and isohelicity with the DNA minor 
groove are able to fit into the DNA groove, usually with no significant change in the 
structure of the DNA.  
For many years now, microcalorimetry has been utilized to decipher the complete 
thermodynamic profiles for a number of drug-DNA complexes.[11] Isothermal titration 
calorimetry (ITC) has been successfully used to parse the thermodynamics of the 
interactions between drug molecules and DNA.[2,3,11] ITC is regarded as the “gold 
standard” approach for the determination of binding affinity data in biomolecular 
interactions. ITC has been used to determine the comprehensive thermodynamic profile of 
these interactions, by determining enthalpy change (H) directly (usually in the presence of 
an excess of the macromolecular binding sites), while determining equilibrium binding 
constant (K), and number of binding sites (n) by model-fitting routines. Free energy change 
(G) and ultimately entropy change (S) are determined from the known thermodynamic 
relationships (G = -RTlnK) and (G = H-TS), respectively. Furthermore, heat capacity 
change (Cp) may be determined from ITC measurements of H over a range of different 
temperatures (Cp = dH/dT).[11]  
In this chapter, we show how isothermal titration calorimetry can be successfully utilized to 
determine relative DNA binding efficacy, as well as the preferred DNA binding mode for a 
selection of homologous series of compounds. By comparing the DNA binding 
characteristics of homologous compounds under identical conditions, we can make robust 
conclusions as to the most important driving force governing the interaction of ligands to 
DNA. The chapter will describe two classes of homologous compounds; the naphthalene 
diimides and chalcogenoxanthyliums. However, the chapter will mainly focus on the 
naphthalene diimide series. The NDI scaffold has been used by several researchers to design 
therapeutically significant candidates [12-20] and are used in our studies as model systems 
to gain additional insight into the binding of “threading” intercalators to DNA. These 
symmetrical molecules have two substituents on either side of the intercalating moiety, thus 
necessitating the threading through or involvement of the side chain during binding 
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(Figure1).[13,14,17-19] In this geometry, one side chain occupies the minor groove, while the 
other lies in the major groove. According to some researchers, a threading intercalator has a 
number of potential advantages since the contact with both DNA grooves provide 
additional potential sites for recognition and targeting.[12-20] The NDI scaffold has 
provided a versatile template for the design of many promising derivatives.[12-20]  
 
(R = ethyl- or propyl-amino side chain) 
Figure 1. General structure of the naphthalene diimides in this study. 
Some NDI derivatives have also been found to selectively bind non-standard structural 
forms of DNA such as triplexes and G-quadruplexes, which are normally transient and 
unstable.[21-25] Stabilization of DNA triplexes formed when oligonucleotides (normally 
referred to as triplex formation oligonucleotide or TFO) bind to DNA duplexes, have been 
explored in anti-gene therapeutics where expression of deleterious DNA sequences are 
suppressed by the binding and stabilization of complimentary TFO sequences.[15,21] 
Formation of transient G-quadruplexes in G-rich sequences have been found to be 
prominent in telomeres, G-rich ends on chromosomes that protects indispensable genes 
from being depleted, as well as preventing unwanted chromosomal fusions.[23-25] As a 
result, some compounds (e.g., certain NDI derivatives) can bind to and stabilize these 
telomeric G-quadruplexes can block access to these sequences by telomerase enzymes, 
which are responsible for extending and protecting telomeres and have been found to be 
over-expressed in 80% of cancers cells.[24,25] G-quadruplexes have also been found to be 
prominent in promoter regions, especially in the promoters of oncogenes such as the c-myc 
and Ras genes, were, found to be directly linked to the formation of certain cancers.[24,25] 
Stabilization of these G-quadruplexes in oncogene promoter regions can block access by 
RNA polymerase, and ultimately blocking expression of these deleterious genes. It is 
therefore important that we continue to probe ligands systems in order to increase our 
understanding of the driving force behind ligand–DNA interactions, and to use this 
knowledge to control their preferred binding mode and sequence. 
The NDI compounds were synthesized as previously described.[26] As mentioned above, 
the NDI scaffold has been used by several groups to design biologically significant 
compounds.[12-20] In the current series, the quaternary amino group in each side chains is 
close enough (ethyl- and propyl-amino linker) to the naphthalene core group to allow 
electrostatic contact with the DNA. Therefore, the cationic quaternary amino groups are 
close to the DNA when the core ring system intercalates between DNA base pairs. As a 
result, there is a greater probability for electrostatic interaction with the phosphates in the 
DNA backbone. The NDI molecules of this study have two substituents on either side of the 
central naphthalene moiety and differ mainly in substituent size and hydrophobicity. That 
means, each compound should adopt a threading molecular geometry when bound to DNA 
via intercalation. Threading NDI compounds analogous to the ones in this study have been 
Applications of Calorimetry in a Wide Context –  
Differential Scanning Calorimetry, Isothermal Titration Calorimetry and Microcalorimetry 132 
under investigation for several years as potential therapeutic (especially anticancer) 
compounds that bind to DNA with improved sequence-selectivity due to their interactions 
with both DNA grooves.  
1.2. Chalcogenoxanthyliums 
Although stored blood used during surgery and in blood transfusion is generally safe due to 
improved screening procedures, there is still a chance (a slight risk) that pathogens within 
the stored blood may be transmitted from donor to recipient.[27,28] This can occur if the 
blood was collected from an infected individual before there were detectable levels of the 
causative pathogen. As a result, there remains a need to develop protocols in which to 
reduce the risk of pathogen transmission, if only in a precautionary or preventative role. 
Photodynamic therapy (PDT) is one approach that has been considered as a viable means in 
which to purge stored blood samples of deleterious pathogens.[27-32] In PDT, light is used 
along with endogenous oxygen and an appropriate photosensitizer (a molecule that has the 
ability to absorb light energy, i.e., photoexcitation, and transfer this energy to another 
chemical entity inducing a change) to treat or reduce an affliction. Photosensitizers are 
effective mainly because they are able to absorb appropriate light energy and produce 
excited triplet states at which time they can transfer energy to ground state oxygen (which is 
also triplet state) via intersystem crossing producing very toxic singlet oxygen species. PDT 
has been used for years in the treatment of certain cancers and lesions, as well as age-related 
macular degeneration. Photofrin, a hematoporhyrin belonging to the porphyrin class of 
compounds, is probably the most well-known and has been used for many years to treat 
bladder cancers. Other photosensitizers include those in the clorin class (e.g., photochlor), as 
well as dyes such as phthalocyanine. 
PDT can be applied in pathogen reduction, especially in the removal of microbial material 
from blood products. In this application, PDT is normally referred to as photodynamic 
antimicrobial chemotherapy (PACT). Compounds containing the xanthylium core 
(rhodamines and rosamines), are among some of the most highly touted class of compounds 
being considered for PACT and have been explored by Wagner, Detty and 
coworkers.[27,31,32] These compounds have been found to selectively accumulate in cancer 
cells and mitochondria, and have also been considered as p-glycoprotein inhibitors and 
mitochondrial stains.[33,34] However, the parent rhodamines and rosamines have been 
mostly ineffective due to short-lived and low yield of triplet excited state upon photo-
excitation. Detty and coworkers have synthesized a group of related chalcogenoxanthyliums 
(Figure 2) that are based on the parent compounds.[33,34] 
X NMe2Me2N
R
 
(X = chalchogen, R = 9-aryl substituent) 
Figure 2. General structure for the chalcogenoxanthylium derivatives. 
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These chalcogenoxanthylium derivatives represent an improvement over the parent 
rhodamine and rosamine since the inclusion of the heavier chalcogen (e.g.,S and Se instead 
of O) provides the known “heavy atom effect” which increases the production of long-lived 
excited triplet states.[33] Furthermore, the substituents (for example, a 2-thienyl instead of a 
phenyl) in the 9-position can be “tuned” such that they absorb light at wavelength that 
avoids hemoglobin attenuation. [33-35] 
To date, PACT has been mostly unsuccessful due largely to 1) low efficacy against 
pathogens, and 2) unwanted background hemolysis of red blood cells.[32] Both these 
shortcomings are mostly due to the non-specific actions of the photosensitizers when 
exposed to the requisite light. To circumvent these problems, photosensitizers that are able 
to target the pathogenic DNA relative to the red blood cells are currently being 
explored.[32,35] One approach to target these pathogens in the presence of red blood cells is 
to use photosensitizers that bind strongly to the pathogenic DNA, since mature red blood 
cells do not contain organelles or genomic nucleic acids.[32,35] The chalcogenoxanthylium 
derivatives are advantageous to use since their substituents can be tuned such that 1) they 
absorb light in a spectral region where light attenuation by hemoglobin absorption is 
avoided, 2) increased yield of singlet excited state that are responsible for destruction of 
pathogens, and 3) their planarity and hydrophobicity can be altered to monitor the effects 
on their interaction with DNA. Thus, offering greater opportunity to potentially reduce the 
incidence of background hemolysis. The DNA binding efficacy and preferred mode of 
binding of a series of chalcogenoxanthylium dyes were investigated by isothermal titration 
calorimetry (ITC).[35] 
1.3. Preference for AT-rich vs GC-rich DNA 
In an effort to decipher the preferred DNA binding mode for compounds in this study, a 
preference for an AT- vs GC-rich sequence will be determined. In order to differentiate 
preferences for intercalation and/or groove binding, the binding of the compounds of this 
study to [poly(dAdT)]2 and [poly(dGdC)]2 were examined by ITC. Figure 3 shows the 
structure of [poly(dAdT)]2 and [poly(dGdC)]2 used in this study. It has long been established 
that known groove binding compounds (e.g., distamycin, berenil, and DAPI) show a strong 
preference (an order of magnitude or greater) for binding to [poly(dAdT)]2 relative to 
[poly(dGdC)]2.[6] The lower affinity for GC-rich sequences shown by groove binders is largely 
due to their restricted access to the minor groove of GC sequences caused by the protruding 2-
NH2 group of guanine. Intercalators are only expected to be affected by this if a substituent is 
placed into the minor groove during formation of the intercalation complex. It is however 
expected that compounds that exhibit mixed binding mode (i.e., intercalation and groove 
binding) will exhibit less (<10) of a preference for the AT sequence.[28,35,36] 
 
Figure 3. AT-rich and GC-rich DNA sequences used in this study. 
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In this chapter, calorimetric data of naphthalene diimide derivatives binding to both calf 
thymus DNA (ctDNA), as well as AT- and GC-rich DNA sequences will be described. The 
binding characteristics of selected chalcogenoxanthylium derivatives will also be compared. 
In an effort to gain insight into the involvement of a minor groove vs. intercalative binding 
mode, the binding of the compounds to [poly(dAdT)]2 and [poly(dCdG)]2 sequences (using 
ITC) will be discussed. The calorimetric approach will be validated using known/classical 
DNA intercalating and minor groove binding compounds. Although the main focus of the 
chapter will be analysis of calorimetric data, the data will also be compared to studies on the 
same systems using ITC-independents approaches such as a gel electrophoresis based 
topoisomerase I DNA unwinding assays and fluorescence-based ethidium bromide 
displacement studies. 
2. Methods and materials 
2.1. Isothermal titration calorimetry   
In general, calorimetric titrations were carried out on a MicroCal VP-ITC (MicroCal Inc., 
Northampton, MA), an instrument specifically suited for studying biomolecular 
interactions. The MicroCal VP-ITC is a highly sensitive microcalorimeter that operates on a 
power compensation method, whereby heat exchange processes occurring in a sample cell is 
compared to a reference cell as the instruments keeps the two cell temperatures identical. 
This results in exothermic processes yielding negative (less than zero) peaks as the 
instrument decreases the power (µcal/s) supplied to the sample cell relative to the reference 
cell, while endothermic processes yield positive (greater than zero) peaks as the instrument 
increases the power supplied to the sample cell compared to the reference cell. The intensity 
of each peak corresponds to the quantity of the heat exchange. The data was analyzed using 
the Origin 7.0 software provided by the manufacturer. Experiments were typically run at 
either 25-30 °C in MES00 buffer (1  10-2 M MES (2(N-morpholino) ethanesulfonic acid) 
containing 1  10-3 M EDTA, with the pH adjusted to 6.25 with NaOH) for runs involving 
calf thymus DNA (ctDNA, ultrapure, Invitrogen). Due to the relative instability of the 
shorter DNA sequence (particularly the AT-rich sequence), experiments using the 
[poly(dAdT)]2 and [poly(dCdG)]2 sequences (Midland Certified Reagents, Midland , TX) 
were done in MES40 (i.e., MES00 with 40 mM NaCl). Note, the MES00 buffer was selected 
for the ctDNA studies due to its low concentration of salt; this would presumably promote 
stronger binding interactions which would yield more intense peaks and thus better 
signal/noise ratios. Typically, either 5 or 12 µL of the drug solution (typically 5-7  10-5 M) 
was injected into a buffered solution of DNA (typically 10-15  10-6 M in bp, 1.4 mL) over 20-
24 s at 240 s intervals using a 250 µL syringe rotating at 300 rpm. The initial delay (hold 
period before injections) was set at 240 s. Before use, samples were degassed at 20 °C using 
the ThermoVac accessory (provided by MicroCal Inc.). During the isothermal titration 
experiments, all injections manifested in a peak that corresponded to the decrease in the 
power (µcal/s) supplied to keep the temperatures of the sample and reference cells 
(containing either water or MES buffer) the same for each injection and represented the heat 
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given off. Note, in all cases, titration peaks corresponded to negative power compensation 
resulting from exothermically driven processes. In each case, response signals were 
corrected for the small heat of dilution associated with the titration of the drug into the MES 
buffer. The heat of dilution for titrating MES buffer into DNA was found to be negligible. 
The heat released (i.e., area associated with negative peaks) on binding of the drug to DNA 
sites was directly proportional to the amount of binding. A binding isotherm of heat 
released (kcal/mol of injectant) versus the molar ratio ([drug]/[DNA] in bp) was constructed 
and the data fitted by non-linear least square fitting analysis to an appropriate model.  
2.2. Topoismerase I DNA unwinding assay 
Typically, 0.24 µg of supercoiled pUC19 plasmid DNA was incubated with human 
topoisomerase I (Topo I) enzyme (Invitrogen) for 5 min at 37 ºC. An appropriate amount of 
the compound of interest was then added (all except for the first two tubes, which serves as 
controls) and the reaction mixture incubated for a further 1 h at 37 ºC. After incubation, the 
reaction was terminated using 0.5% SDS and 0.5 mg/mL proteinase K. Both the enzyme and 
compound of interest was then extracted using a mixture of phenol:chloroform:isoamyl 
alcohol (25:24:1). The remaining DNA sample was then run on an agarose gel (1%) at 75 V 
for 3 h, stained with ethidium bromide for 45 min and photographed. 
2.3. Ethidium bromide displacement assay 
A solution of ethidium bromide (EtBr, 5  10-6 M, 1.0 mL) was pre-incubated with ultrapure 
calf thymus DNA (1  10-5 M in base pairs, 1.4 mL) obtained from Invitrogen. at room 
temperature (22-23 C) for 15 min in MES00 buffer, pH 6.3. Aliquots of exactly 3 L of the 
compound (7  10-5 M) were then titrated into the EtBr-DNA solution and the change in 
fluorescence measured (Photon Technology International fluorometer), after 3 min 
incubation periods (excitation 545 nm and emission 595 nm). The addition of 3 L aliquots 
was continued until the DNA was saturated (i.e., no further change in fluorescence due to 
EtBr displacement). [28,36] Control experiments showed that the compounds (free or DNA-
bound) had no significant background fluorescence at the excitation (545 nm) and emission 
(595 nm) wavelengths of EtBr. 
3. Results and discussion 
3.1. Using relative binding affinity for AT- vs GC-DNA to evaluate binding 
mode 
In order to validate the approach of using relative preferences for AT vs GC to ascertain the 
preferred DNA binding mode, several known/classical DNA binding compounds were 
investigated using ITC. These include two compounds known to bind DNA via the minor 
groove, distamycin A and berenil, (Figure 4) and two compounds known to bind DNA via 
intercalation (ethidium bromide, normally regarded as the classical DNA intercalator, and 
daunomycin) (Figure 5).[2,3,6] 
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Isothermal titration calorimetric data for distamycin, berenil, daunomycin and ethidium 
bromide binding to the AT- and GC-rich sequences are shown in Figure 6. As can be seen 
from the raw data, both minor groove binders distamycin A and berenil show a strong 
preference for the AT-rich sequence relative to the GC-rich sequence. In fact, ITC signals for 
each compound binding to the GC-rich sequence was found to be negligible, showing only 
background signal that was associated with the heats of dilution when the compound was 
titrated into the cell buffer. Binding constants found for distamycin A and berenil binding to 
the AT-rich sequence were 2.20±0.4 x 107 M-1 and 1.76±0.3 x 106 M-1, respectively.  
 
Figure 4. Structures of some common DNA minor groove binding compounds. 
A different result was observed with the classical DNA intercalator, ethidium bromide and 
the known chemotherapeutic DNA intercalator, daunomycin. The isothermal calorimetric 
data for ethidium bromide and daunomycin showed binding to both the AT- and GC-rich 
sequences and indicated no significant preference for either sequence. Binding constants 
obtained for the AT-rich and GC-rich sequence were 1.78±0.5 x 105 M-1 and 3.38± 0.8 x 105 M-
1, and 2.93±0.63 x 106 M-1 and 3.24±0.60 x 105 M-1, for ethidium bromide and daunomycin, 
respectively.  
 
Figure 5. Structures of two common DNA intercalators.  
The results observed for distamycin A, berenil, ethidium bromide and daunomycin are 
consistent with both distamycin A and berenil binding via the minor groove, since each 
compound showed a significant preference for the AT-rich sequence, while as expected, 
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ethidium bromide and daunomycin bind DNA via intercalation, since neither exhibited a 
significant preference. This is suggested from the fact that the minor groove in the GC-rich 
sequence is partially blocked by the protruded 2-NH2 group of guanine, preventing a 
compound that uses the minor groove for DNA binding to be blocked.[6] This is not the case 
for the AT-rich sequence. On the other hand, a compound such as ethidium bromide and 
daunomycin which intercalates into DNA by sliding between adjacent base pairs, will 
essentially be unimpeded from binding to either the AT or GC-rich sequences. The reported 
binding modes for distamycin A, berenil, ethidium bromide and daunomycin herein are 
also consistent with the wealth of literature reports on the binding mode for all four 
compounds, thus validating our approach.[2,3,6,8,10,37,38] 
 
Figure 6. Calorimetric data for the titration of 60 µM of the compounds (from left to right): distamycin 
A, berenil, daunomycin and ethidium bromide into 15 µM of AT-rich DNA (top), GC-DNA (bottom) at 
30 C. Binding isotherms (heat change vs drug/DNA molar ratio) were obtained from the integration of 
raw data and fitted to a “one-site” model 
4. Binding of the NDI derivatives to DNA using ITC 
As was mentioned earlier, the NDI class of compounds is an excellent model system to 
study DNA binding interactions especially since it offers a useful platform for the syntheses 
of many homologous series. These molecules are threading intercalators in which side 
chains on either side of the main intercalating moiety provides the potential for specific 
recognition sites on the DNA.[12-19] The specific roles of a variety of substituents will be 
studied with a focus on identifying differential contributions from each moiety. A 
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quaternary amino group will also be incorporated into each NDI side chain to provide 
electrostatic interaction with the negatively charged DNA backbone. The NDI derivatives in 
this chapter (Figure 7 and 8) were synthesized by Dixon and coworkers and have three main 
motifs.[26,36] 
Ring Size: Compounds that contains a ring (N-methyl pyrrolidine or N-methyl piperidine) at 
the distal end of the side chain, as well as possessing different ring size. To date, the effect of 
ring size on intercalator-DNA interaction has been mostly unexplored. We have studied two 
homologous types of NDI that differ by a single carbon with five- vs six-membered 
heterocyclic rings. These are at identical distances from the main intercalating moiety. The 
rings are non-aromatic and are not expected to stack with the DNA bases. However, they 
differ in steric bulk which should have implications during binding. One could predict that 
NDI-3 will show relatively lower binding affinity than NDI-4, however, the increase in 
bulkiness might have only kinetic consequences.26 We are interested in determining whether 
these substituent variations might have an effect on both the preferred DNA binding mode 
adopted by these compounds, and consequently their relative DNA binding affinity. We 
also compare the effect of having a cyclic structure in the side chain vs. acyclic alkyl 
substituents. 
Linker length: Insights into the effect of changing the linker length for two sets of NDI 
derivatives (acyclic aliphatic and cyclic aliphatic substituents) will be discussed. In both sets 
of compounds, the side chain linker length differ by one carbon (ethyl vs propyl). This 
means the quaternary amino group (present in all the NDI compounds) is one carbon 
further from the main intercalating core for the propyl linker. For the acyclic aliphatic 
derivatives, we compare the trimethyl-propylamino (NDI-1p) and dibutylmethyl-
propylamino (NDI-2p) derivatives (that are one carbon further from the main intercalating 
core) to the trimethyl-ethylamino (NDI-1e) and dibutylmethyl-ethylamino (NDI-2e) 
derivatives. For the cyclic aliphatic compounds, the ethyl-linker-containing compound, 
NDI-3, is compared to the propyl-linker-containing NDI-5. Given the difference in steric 
bulk of the cyclic aliphatic compared to the acyclic derivatives, there may be steric 
consequences. We will also be able to gain insights into acyclic vs. cyclic substituent effects 
on DNA binding. 
Substituent length/size: In order to gain additional insights into the role of the side chain 
size, an analysis of the DNA binding characteristics of NDI compounds that differ in the size 
and side chain linker-length of their alkyl-amine side chain will also be done. As the length 
and size of the substituent increases, so does the steric bulk. Of course, hydrophobicity also 
increases with substituent size. We seek to investigate the effects of steric bulk and 
hydrophobicity on DNA binding of these derivatives. Hydrophobicity has been reported to 
be a significant driving force in DNA binding interactions with binding increasing with 
hydrophobicity.[2,3] We have investigated the relative importance of this factor using a 
model NDI series in which size/steric contributions should also be a factor. Both 
hydrophobicity and molecular size increases along the series. If hydrophobicity is the 
predominant driving force, then one might expect binding to increase with 
size/hydrophobicity. However, if a size/steric effect dominates, binding should decrease.  
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Figure 7. Representative structure for the acyclic NDI derivatives, showing the ethylamino (ethyl 
linker) side chain derivatives [NDI-1e (bottom, left) and NDI-2e (bottom, right)] and the propylamino 
(propyl linker) derivatives [NDI-1p,(top, left) and NDI-2p (top, right)]. 
 
Figure 8. Structures for the cyclic ethylamino NDI derivatives [NDI-3 (top, left) and NDI-4 (bottom, left)] 
and the cyclic propylamino derivatives NDI-5 (right). Both NDI-3 and NDI-5 contain a side chain N-
methyl pyrrolidine five-membered ring, while NDI-4 contains a six-membered N-methyl piperidine ring. 
5. Effect of the side chain ring size and linker length  
In general, the inclusion of a cyclic component in the side chain resulted in a biphasic raw 
calorimetric data for each cyclic NDI compound binding to DNA (Figure 9). The raw 
calorimetric data for the cyclic compounds binding to ctDNA were best defined by a model 
that assumes two types of binding sites (K1, K2) and argues for the involvement of at least 
two different types of binding modes for the compounds with ring-containing substituents. 
This biphasic binding mode has been reported by us for larger members of an acyclic 
substituent NDI series and will be briefly discussed below.[36] In general, the higher 
binding constant (K1) for the cyclic NDI derivatives was in the order (~107-108 M-1), while a 
lower binding constant (K2) was in the order of (~106 M-1) for compounds possessing the N-
methyl pyrrolidine ring (NDI-3 and NDI-5) binding to ctDNA. The DNA binding constant 
for the N-methyl piperidine derivative (NDI-4) showed strong but significantly lower 
binding constants compared to the N-methyl pyrrolidine derivatives. Calorimetric data for 
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the two compounds that differed only in ring size (N-methyl pyrrolidine vs N-methyl 
piperidine) showed that NDI-3 (N-methyl pyrrolidine substituent) exhibited larger binding 
constants (K1 = 1.17± 0.3 x 108 M-1, K2 = 5.6±0.65 x 106 M-1) as compared to larger NDI-4 
(K1=1.70 ±0.4 x 107 M-1 and K2=3.26 ±0.54 x 106 M-1) when binding to ctDNA. Thus both 
binding constants were lower for the larger N-methyl piperidine derivative. Given that 
NDI-4 possesses a more bulky N-methyl piperidyl substituent suggest that steric hindrance 
may play a role here. Studies on a series of NDI containing acyclic substituents also found two 
binding constants; one binding constant was found to be as a result of intercalation, while the 
other was found to via a non-intercalative mode, presumably via the DNA minor groove.[36] 
Assuming that the two binding modes found for the cyclic substituents here are similar (given 
the similarities between the two sets of compounds), the two binding modes found here for the 
cyclic derivatives are presumed to also be via intercalation (lower binding constant , K2) and 
minor groove binding (higher binding constant, K1). In which case, NDI-4 with its larger more 
bulky substituent may find difficulty in sliding itself through adjacent base pairs. This is of 
course a requirement for intercalation. Furthermore, given that these compounds possess two 
substituents on either side of the main intercalating moiety (i.e., threading), one substituent 
must “thread” through DNA base pairs if it is to adopt an intercalating geometry. Since both 
binding constant decrease for the N-methyl piperidine derivative, the second binding mode 
(i.e., presumed to be via the minor groove) is also affected sterically.  
According to the calorimetrically determined binding constants, the linker length did not 
appear to have significant role for these cyclic side chain containing derivatives since NDI-5 
(ethylamino/ethyl linker) and NDI-3 (propylamino/propyl linker) both had very similar 
binding constants for both the higher and lower binding sites (K1 = 1.08 x 108 M-1, K2 
=5.1±0.72 x 106 M-1 and K1 = 1.17± 0.3 x 108 M-1, K2=5.6±0.65 x 106 M-1, respectively). It 
therefore appears that the size of the cyclic substituent plays a greater role than the 
substituent linker in determining the DNA binding affinity. 
 
Figure 9. Calorimetric data for the titration of 60 µM NDI-4 (left), NDI-3 (middle) and NDI-5 (right) 
into 12.5 µM of ctDNA at 30 C. Binding isotherms (heat change vs drug/DNA molar ratio) were 
obtained from the integration of raw data and fitted to a “two-site” model. 
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6. NDI binding mode determination via AT vs GC preference of the 
cyclic NDI derivatives 
Calorimetric studies were carried out to evaluate preferences for AT vs GC-rich sequences, 
in an effort to detect a possible minor groove binding mode, implied by the above result  
(Figure 10). In general, the cyclic NDI derivatives possessing the ethylamino linker (NDI-3 
and NDI-4) exhibited a roughly two-fold preference (2.0x for NDI-3, 2.4x for NDI-4) for the 
AT-rich sequence relative to the GC-rich sequence (Table 1). The difference in affinity for 
the AT- vs GC-rich sequence is similar to at least one of the acyclic substituent NDI 
compounds (a dipropylmethyl ethylamino side chain) reported in an earlier study (see 
section on the acyclic derivatives below), and which was suggested to have a second minor 
groove binding mode.[36] We therefore suggest here that the cyclic NDI derivatives NDI-3 
and NDI-4 does have a minor groove binding mode. It is interesting to note that NDI-4 
showed a slightly greater preference for the AT-rich DNA sequence compared to NDI-3, 
implying a greater involvement of minor groove binding for NDI-4. 
The cyclic derivative with the propylamino linker (NDI-5) exhibited even less of a 
preference (~1.4x). However, the difference between the NDI-5 binding constant for AT vs GC-
rich sequences could be considered as the same within experimental error. This result may 
imply that there is a greater contribution from non-intercalative binding from the cyclic 
ethylamino derivatives relative to the propylamino derivatives. This result is somewhat similar 
to what was observed in the series of acyclic substituent NDI derivatives. However, given the 
small differences in AT vs GC-sequences, this would warrant additional studies to confirm. 
 
Figure 10. Calorimetric data for the titration of 60 µM NDI-5 (left), NDI-3 (middle) and NDI-4 (right) 
into 15 µM of AT-rich DNA (top), GC-DNA (bottom) at 30 C. Binding isotherms (heat change vs 
drug/DNA molar ratio) were obtained from the integration of raw data and fitted to a “one-site” model. 
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7. DNA binding mode determination using ITC-independent approaches 
Two additional approaches were also utilized to determine the binding mode involved for 
the compounds in this study. These were a topoisomerase I DNA unwinding assays (topo 
assay) and ethidium bromide (EtBr) displacement studies. A brief description of the two 
techniques is in order. Briefly, the topo assay exploits the ability of topoisomerase I enzyme 
to relax supercoiled DNA, such as the plasmid pUC19 used in all our studies.[39,40] Under 
the conditions of our topo assay, supercoiled plasmid pUC19 DNA is first relaxed by using 
excess topoisomerase I enzyme and then is exposed to the compound under study. After 
extraction of the compound and enzyme, a compound that was bound via intercalation will 
cause re-supercoiling of the plasmid DNA. Re-supercoiling is due to the change in DNA 
linking number that accompanies relaxation by the topoisomerase enzyme and occurs to the 
extent to which the intercalator molecule was initially bound.[39,40] An intercalating 
molecule will perturb the DNA such that the DNA will unwind, causing the topoisomerase 
enzyme (which is present in excess) to relax the DNA, thus changing the linking number. 
The extent to which DNA unwinding occurs will be dependent upon the extent to which 
DNA binding occurs, thus the minimum concentration needed to cause complete re-
supercoiling will be indicative of how much compound was initially bound and thus the 
relative binding affinity. Conversely, minor groove binders should not induce appreciable 
re-supercoiling due to negligible DNA unwinding upon binding, and negligible change in 
DNA linking number.  
With the EtBr displacement assays, EtBr, a known intercalator is first bound to DNA, 
occupying its intercalative sites. The compound of interest is then added to determine 
whether it is able to displace EtBr from its intercalative sites. Displacement is monitored by 
a decrease in EtBr–DNA fluorescence.[28,36,41] It is well established that the fluorescence 
yield of EtBr is enhanced significantly when it binds to DNA. This occurs as EtBr occupies 
its intercalative sites between bases in the DNA molecule. However, in the presence of 
another intercalator, there is competition for a limited/defined number of intercalation sites. 
As the other intercalator molecules are added, they begin to displace EtBr from these 
intercalative site, increasing the amount of free (unbound) EtBr. This is usually observed as 
a decrease in EtBr-DNA fluorescence. 
Both the topo assay and ETBr displacement assays has been used by our group, as well as 
other groups, to determine DNA binding mode of DNA binding compounds.[28,35,36,41,42] 
To validate the topo assay approach, we have run assays on several known DNA binding 
compounds. These include the classical DNA intercalator, EtBr, and known minor-groove 
binding compounds such as distamycin A, berenil. Figure 11 shows representative topo 
assay for EtBr and berenil.[42] As is expected, the classical DNA intercalator, EtBr, was able 
to elicit significant re-supercoiling back to the levels of the control (lane 1), whereas, the 
known minor groove binding compound was unable to do so, even at the high 
concentrations. In fact, essentially no re-supercoiling was observed for berenil, confirming 
its known minor groove binding mode. Similarly, we have done validation studies of our 
EtBr displacement assay, by running studies on DNA binding compounds in which their 
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binding modes have already been established (e.g., distamycin A and berenil). As expected, 
none of the compounds known to be minor groove binders were able to cause appreciable 
displacement of EtBr from its intercalative sites, consistent with these compounds binding to 
non-intercalative sites (Table 1). However, the intercalating molecules were able to displace 
ethidium bromide effectively, as was evident by the significant decrease in EtBr-DNA 
complex fluorescence. 
 
Figure 11. Topo I assay of of the classical DNA intercalator EtBr (left) and the known minor groove 
binder berenil (right) using 5 units of the topoisomerase enzyme. From left of each gel, lanes 1 contain 
only DNA (no compound nor topoisomerase) and serve as controls. Lanes 2 contain DNA and 
topoisomerase, but no compound. Remaining lanes contain DNA, topoisomerase and increasing 
concentrations of compound (taken from [42]). 
8. Binding mode determination of cyclic NDI derivatives via ITC-
independent approaches 
When topo assays were done on the NDI derivatives containing the cyclic amino side chains 
(NDI-5, NDI-3, and NDI-4), each compound was able to cause re-supercoiling, indicating 
that intercalation is indeed involved in the binding of each compound to DNA. This was not 
surprising since NDI compounds are known to bind to DNA via intercalation.[17-19] 
However, NDI-3 was better able to elicit re-supercoiling than NDI-5, which was in turn 
better than NDI-4. That is, while NDI-3 was able to cause complete re-supercoiling of our 
plasmid DNA at ~6 µM, NDI-4 requires >10 µM for complete re-supercoiling (Table 1). This 
suggests that the binding of NDI-3 involves more of an intercalative mode than either NDI-
5 or NDI-4 and is consistent with what was observed in the ITC studies for these 
compounds described above. That is, the strength of the lower binding constants (K2) was in 
the order NDI-3>NDI-5>NDI-4. The lower binding constant (K2 in this report), has been 
found to be that of the intercalative binding mode for a similar series of NDI.[36] It appears 
that the bulkier N-methyl piperidine is either sterically hindering intercalation, or forcing 
NDI-4 into a more non-intercalative binding mode, while NDI-5, with its propylamino 
linker, exhibits lower affinity for the DNA as compared to NDI-4. The lower binding affinity 
associated with the propylamino linker will be addressed later.  
The behavior of the cyclic substituent NDI compounds in the ITC studies and topo assays 
were also consistent with our EtBr displacement studies which showed that NDI-3 was 
better able to displace EtBr from its intercalative sites; thus NDI-3 caused a greater decrease 
in EtBr fluorescence compared to NDI-4 (Table 1). Our EtBr displacement assays also 
showed that NDI-5 was able to displace EtBr to the same extent as NDI-3, suggesting that 
both have a similar intercalative strengths. Again, this is consistent with what we observed 
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in the ITC and topo assay studies described above. That is, NDI-5 and NDI-3 having very 
similar K2 (ITC), and both eliciting re-supercoiling of the plasmid DNA at roughly similar 
concentrations.  
 
Compound 
Kb (ctDNA) 
(106 M-1) 
(ITC)a 
Kb (AT) 
(106 M-1) 
(ITC)b 
Kb (GC) 
(106 M1) 
(ITC)b 
Topo assay
(10-6 M)c 
 
EtBr 
displacement 
Assay 
(F/µL)d 
distamycin A --- 2.20 ± 0.4 --- --- 6 
Berenil --- 1.76 ±0.3 --- --- 31 
EtBr --- 0.18±0.05 0.34±0.08 2 --- 
daunomycin --- 2.9 ±0.6 3.24±0.6 --- --- 
NDI-1e 15±3 1.11±0.27 1.17±0.10 3.5 400 
NDI-2e 
78±23 
3.9±1.1 
1.38±0.15 0.38±0.09 >6.7 358 
NDI-1p 1.22±0.16 10.1 ±0.7 --- 3 --- 
NDI-2p 0.57 ± 0.2 8.7 ±0.4 --- 5 --- 
NDI-3 
117±30 
5.66±0.65 
0.5±0.09 0.25±0.05 6 949 
NDI-4 
17.0±4 
3.26±0.54 
0.39±0.08 0.16±0.04 >10 777 
NDI-5 
104± 35 
5.10±0.72 
1.16±0.24 0.85±0.09 >6 1030 
a MES00 buffer, pH 6.25  
b MES40 buffer, pH 6.25. 
c Minimum concentration required for complete re-supercoiling. 
d Decrease in EtBr fluorescence per µL of compound added. 
Data for acyclic NDI-#e series are from reference [36]. 
Data for the acyclic NDI-#p series are from reference [42]. 
Table 1. Representative DNA binding affinity data for the compounds in this study. 
9. Effect of the length/size of the substituent and linker length (Ethyl vs 
propyl) 
As was reported by us, data obtained from calorimetric measurements show that the 
length/size of the substituent plays a significant role in both the preferred binding mode and 
relative binding affinity of the compounds of these studies.[36] The compounds of this study 
showed tight binding to DNA with values of Kb between 105 to 108 M-1, presumably 
dependent on their preferred mode of binding to DNA. Figure 12 shows the calorimetric 
data for the four acyclic NDI derivatives (with ethylamino side chain linkers) binding to 
ctDNA. In that report, we found only a single type of binding constant (binding mode) for 
the smallest compound in the series (containing a trimethyl-ethylamino side chain).[36] This  
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Figure 12. Calorimetric data (raw) for the acyclic ethylamino derivatives binding to ctDNA. In each 
case, 70 µM of the NDI was titrated into ctDNA (12.5 µM) at 30 C. Data is shown for the trimethyl 
ethylamino derivative NDI-1e (top, left), diethylmethyl ethylamino derivative (top, right), 
dipropylmethyl ethylamino derivative (bottom, left), and the dibutylmethyl ethylamino derivative 
NDI-2e (bottom,right). Binding isotherm (heat change vs drug/DNA molar ratio) was obtained from the 
integration of raw data and fitted to either a “one-site” model (NDI-1e) and a “two-site” model (all 
others). The plot for NDI-1e and NDI-2e were taken from [36]. 
was indicated by a single-phased binding isotherm that was well-defined by a one-site 
binding model. Larger members of the ethylamino series (diethylmethyl-, dipropylmethyl- 
and dibutylmethyl-ethylamino substituents) adopted two binding modes; a lower affinity 
binding mode between 3-4 x 106 M-1 and an additional higher affinity binding mode of 
between 31 - 78 x 106 M-1.[36] This was indicated by a biphasic binding isotherm that was 
fitted well to a two-site model; one site associated with intercalation and the other 
associated with minor groove binding. If we compare the results found for the smallest 
compound in that study, with that of the smallest compound in another study done by us 
with a similar NDI series with propylamino linker instead,[42] we find that only a single 
type of binding mode and binding constant (NDI-1e, K = 15±3 x 106 M-1 and NDI-1p, K = 1.2 
Applications of Calorimetry in a Wide Context –  
Differential Scanning Calorimetry, Isothermal Titration Calorimetry and Microcalorimetry 146 
±0.16 x 106 M-1) is found for the smallest member of the series whether the side chain is 
ethylamino or the one-carbon longer, propylamino substituent.[36,42] However, whereas 
larger members in the acyclic ethylamino series exhibited a dual binding mode, neither 
compound in the acyclic propylamino series (referred to as NDI-1p or NDI-2p in this 
chapter) was found to exhibit more than one binding mode. Additionally, in the ethylamino 
series, we observe that the relative binding affinity trend for the ethylamino series increased 
with substituent size. However, this feature was not observed in the propylamino series 
(one carbon longer on both sides of the main intercalating moiety), since NDI-2p with its 
dibutylmethyl-propylamino substituent exhibited a lower binding constant (0.57±0.17 x 106 
M-1) compared to smaller homolog (NDI-1p) which had a binding constant of (1.2±0.16 x 106 
M-1), a binding mode attributed to intercalative binding.[42] It is also clear that DNA 
binding affinity was in general greater for the ethylamino derivative, although some of this 
difference may be attributed to slightly different experimental conditions used in the two 
studies. It therefore implies that this small structural difference may (1) enable an additional 
mode of binding, i.e., a linker length that is one carbon shorter resulted in an additional 
binding mode, as well as (2), enhance the DNA binding mode by greater than an order of 
magnitude. An explanation for this could be that steric effects may dominate for the propyl-
amino series, resulting in lower DNA binding, especially for the larger members, while 
hydrophobic and binding mode preferences may be dominant in the ethyl-amino series. The 
propyl amino derivatives are of course longer especially since the additional carbon linker is 
on both sides of the molecule, given that these are threading compounds. The longer (more 
dangling) molecular structure may make it more difficult to thread through adjacent base 
pairs. However, in the case of the ethylamino series, the solution for the larger substituents 
appear to be adoption of an additional DNA binding mode. Hydrophobic contributions may 
also play a role. 
10. Comparison of binding mode for NDI derivative with ethyl vs propyl 
linker using topo assay 
Comparing the two series with different linker-length (i.e., ethylamino vs propylamino 
derivatives), it is also interesting to note that generally higher concentrations of the 
ethylamino derivatives were required for re-supercoiling, despite having higher binding 
constants as determined by ITC.[36,42] A striking example of this is seen from the fact that 
more than 6.5 uM of NDI-2e (K1= 78±23 x 106 M-1 and K2=3.9±1.1 x 106 M-1) was required for 
supercoiling, while the corresponding propylamino derivative NDI-2p with a significantly 
lower binding affinity (K = 0.57±0.17 x 106 M-1) required only 5 uM. Again, some of this may 
also be attributed to different experimental conditions. For example, a greater excess of the 
topoisomerase enzyme was used in the assays for the ethylamino series. However, this 
factor alone cannot account for the lack of associated re-supercoiling ability given the 
disproportionately higher DNA binding constants for the ethylamino derivatives. Overall, a 
side by side comparison of the topo assay results for the two series (ethylamino vs 
propylamino) suggests that the ethylamino derivatives displays relative re-supercoiling 
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capabilities that are less than expected based on their significantly higher binding affinities. 
Since the ability to elicit re-supercoiling is primarily based on an intercalative ability, this 
argues for a greater involvement of non-intercalative binding for ethylamino derivatives 
relative to their propylamino counterparts. 
11. Binding of the chalcogenoxanthylium derivatives to DNA 
In an effort to further corroborate our DNA binding characterization approach used for the 
NDI derivatives discussed above using a different/independent homologous series, we will 
also briefly describe DNA binding studies of a homologous series of chalcogenoxanthylium 
derivatives to DNA, reported by our group.[35] The chalgenoxanthylium derivatives in this 
study were synthesized by Detty and coworkers and have been implicated as potential 
candidates for therapy against blood-borne pathogens.[27,31-33,35]. 
Using this independent system as a comparison, we have also found that the results 
obtained from ITC were consistent with that found using topo assay and EtBr displacement 
studies. These studies have found that the nature of the substituent attached to the main 
xanthylium core plays a directing role in the preferred binding mode and accompanying 
DNA binding affinity.[35] While some of the compounds bind to DNA either through 
intercalation or via the minor groove, some exhibited mixed-binding modes.[35] Excerpts 
from the DNA binding studies for selected chalcogenoxanthylium derivatives (Figure 13) 
will now be discussed. 
In that report, ITC studies suggested that both the 9-substituent and the identity of the 
chalcogen play a role in the preferred binding mode and ultimately, the relative DNA 
binding constant.[35] With a 9-2 thienyl substituent attached to the main xanthylium core 
(e.g., 2-Se), there appeared to be a preference for intercalation. This was implied from the 
fact that compounds containing the 9-2 thienyl substituent showed no preference for the AT-
rich sequence, a feature that would be typical for a minor-groove binder. The 9-2 thienyl 
also bound to calf thymus DNA with lower affinity as compared to the 9-phenyl derivatives 
(e.g.,1-Se).[35] DNA intercalators are known to have lower DNA binding affinity as 
compared to minor-groove binders,[2] so this result may be due to a greater contribution 
from minor groove binding (i.e., less contribution from intercalation) with the 9-phenyl 
series. In addition to exhibiting a 2-3 higher binding constant compared to the 
corresponding 9-2 thienyl derivative, the 9-phenyl series exhibited a slight preference (2-3 
times) for binding to [poly(dAdT)]2 as compared to the [poly(dGdC)]2. Here again, a 
possible minor groove binding was implied, since it is known that compounds that bind 
solely to the DNA minor groove generally show a preference for binding to AT-rich 
sequences relative to GC-rich sequences due to the occlusion from the GC-rich minor groove 
by the protruded 2-NH2 group of guanine.[6] As mentioned for the NDI series discussed 
earlier, it is expected that compounds that bind both via the DNA minor groove and by 
intercalation (i.e., mixed binding modes) will show a factor of <10 preference for AT-rich 
sequences, depending on the relative contribution from intercalation (i.e., the difference will 
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be less as contributions from intercalation increases). The chalcogenoxanthylium derivative 
bearing a 9-(2-thienyl-5-diethylcarboxamide) substituent (compound 10) exhibited the 
strongest preference for the [poly(dAdT)]2 sequence. In fact, compound 10 showed 
essentially no binding to the [poly(dGdC)]2 sequence, while binding to [poly(dAdT)]2 with a 
K of 2.3 ±0.4 x 106 M-1.[35]  
 
Figure 13. Structures of selected chalcogenoxanthylium derivatives reported in [35]. The 9-2 thienyl 
derivative (2-Se, left) shown bind mostly via intercalation, while 1-Se derivative (middle) is a mix-
binder, and compound 10 binds primarily via the DNA minor groove. 
12. Binding mode determination of chalcogenoxanylium derivatives via 
ITC-independent approaches 
As was done for the NDI series discussed earlier, several independent (non-ITC) studies 
(ethidium bromide displacement and topo assay) were also carried out on the 
chalcogenoxanthylium derivatives in this study.[35] This was done in an effort to gain 
additional insights into the preferred DNA binding mode suggested by ITC. 
Results from topo assays have been reported by us.[35] These results were in general 
consistent with the ITC studies on these compounds. We will now report new EtBr data on 
chalcogenoxanthylium derivatives discussed in this chapter that supports both ITC and topo 
assay studies. 
Further evidence for the preferred DNA binding modes were also observed during 
ethidium bromide displacement assays on selected members of the chalcogenoxanthylium 
compounds binding to DNA. These were the seleno derivatives from the 9-2 thienyl series 
(2-Se), the 9-phenyl series (1-Se), and compound 10 (suggested to have primarily a non-
intercalative binding from the ITC studies). While compound 2-Se and 1-Se were both able 
to cause dislodgement of ethidium bromide from DNA, 2-Se was markedly better able to do 
so (decrease in fluorescence per µL of compound added was: 2-Se = 711, 1-Se = 581, 
compound 10 = 350. Considering that part of the change is fluorescence for the compounds 
was due to accompanying dilution during the titration, we see here that the order of 
intercalative ability is 2-Se>1-Se>10. This order mirrors the results from both ITC and topo 
assay which showed that 2-Se was a better intercalator than 1-Se, which was in turn better 
than compound 10. This implies that 2-Se is a stronger intercalator than 1-Se, consistent 
with both the ITC and topo assay studies. Compound 10 caused relatively small decreases in 
ethidium bromide fluorescent (less than any of the NDI derivatives in this study) indicating 
that it is not a potent displacer of ethidium bromide from its intercalative sites, suggesting 
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that compound 10 is not a strong intercalator, again consistent with the minor groove 
binding mode implied by both the ITC and topo assay. Given the higher binding constant 
found for 1-Se relative to 2-Se using ITC, if 1-Se was primarily a DNA intercalator, it would 
exhibit a greater ability (compared to 2-Se) to dislodge the classical DNA intercalator EtBr 
from its binding sites. The fact that it did not, strongly supports the idea that the binding of 
1-Se to DNA involves other binding modes. Also, the fact compound 10 showed little ability 
to dislodge ethidium bromide from DNA, while having the highest binding constant (as 
determined by ITC studies in an earlier study [35]), supports the idea of compound 10 
involving significant non-intercalative DNA binding (presumably, via the minor-groove). 
13. Conclusions 
In this chapter, we have shown how ITC can be successfully used to characterize both the 
preferred DNA binding mode for series of compounds, as well as their relative DNA 
binding affinity. For this, we have selected two homologous series of compounds; series of 
symmetrical NDI threading intercalators in which the side chains are mandatorily involved 
in DNA binding, and a series of chalcogenoxanthilum derivatives. Both classes of 
compounds have been shown to have biological activity.  
While the homologous NDI derivatives in this study all exhibit DNA intercalative abilities, 
the substituent on either side of the main intercalating core does play a significant role in 
determining whether or not additional modes are adopted. This occurs because these 
compounds require a threading geometry when intercalating between DNA base pairs, i.e., 
there is a necessity for the side chain to “thread” DNA. The side chains are therefore forced 
to direct DNA binding. We have found that the cyclic (non-aromatic) substituent at the 
distal end of a side chain play a significant role in both the DNA binding affinity and the 
preferred mode of binding. Larger ring sizes face steric barriers and have lower DNA 
binding affinity. The larger rings may however force additional (non-intercalative) binding 
modes to be involved. Additional studies may be needed to fully understand the full effects 
of ring size. Future studies may involve attachment of aromatic rings instead of non-
aromatic rings in this study. Having flat aromatic rings on the substituent may enhance site 
recognition and DNA binding due to the ability to stack. We have also found that even a 
small modification in the linker length in NDI side chain play a significant role during 
binding of NDI derivatives of acyclic aliphatic side substituents to DNA. In fact, on 
comparing side chains with an ethyl linker vs those with a propyl linker, it was found that 
the ethyl linker could enhance DNA binding by more than an order of magnitude. 
Possession of the ethyl linker also enabled an additional DNA binding mode of higher 
affinity. The NDI scaffold therefore represent a versatile template for the design of many 
promising derivatives with enhanced DNA affinity and have implications in the rationale 
design of DNA binding compounds with improved site recognition capabilities. 
Using an independent system for comparison, the approach of using ITC to study binding to 
both ctDNA and AT vs GC-rich sequences, was shown to be an efficient and consistent 
approach in the determination of relative DNA binding affinity and preferred DNA binding 
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mode. The ITC studies were well corroborated by ITC-independent studies such as topo 
assays and EtBr displacement studies, thus exhibiting the efficacy of our approach. 
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